SCHEMBL12347759

SCHEMBL12347759

CC(C)(C)C(=S)Nc1ccc(F)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.59
ALDH1A1 P00352 2/20 0.59
ALOX12 P18054 1/20 0.59
GAA P10253 2/20 0.52
IDO1 P14902 1/20 0.52
MEN1 O00255 4/20 0.52
KMT2A Q03164 4/20 0.52
POLB P06746 1/20 0.52
MAPT P10636 4/20 0.50
MAPK1 P28482 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 2/20 0.50
NPC1 O15118 1/20 0.50
XBP1 P17861 1/20 0.50
RAB9A P51151 1/20 0.50
MAOA P21397 1/20 0.50
MAOB P27338 1/20 0.50
NOX1 Q9Y5S8 1/20 0.48
KDM4E B2RXH2 1/20 0.47
THRB P10828 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25474912 0.81 TDP1 (0.56) ALDH1A1GAAMEN1KMT2APOLB
SCHEMBL14447512 0.78 TAS2R38 (0.58) LMNAALDH1A1ALOX12GAAMEN1
SCHEMBL14447524 0.76 MAPT (0.61) LMNAALDH1A1GAAMEN1KMT2A
SCHEMBL24534286 0.76 HTT (0.68) LMNAALDH1A1ALOX12GAAMEN1
SCHEMBL24016404 0.76 RAB9A (0.51) LMNAALDH1A1ALOX12GAAMEN1
SCHEMBL11738124 0.76 MEN1 (0.62) LMNAALDH1A1ALOX12GAAIDO1
SCHEMBL72846 0.75 L3MBTL1 (0.79) LMNAALDH1A1ALOX12MEN1KMT2A
SCHEMBL10099725 0.75 GAA (0.83) LMNAALDH1A1GAAIDO1MEN1
SCHEMBL22966368 0.75 ESR1 (0.48) LMNAALDH1A1ALOX12GAAMEN1
SCHEMBL26552897 0.75 HPGD (0.40) LMNAALDH1A1ALOX12GAAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110201794-A1 Disaccharides for drug discovery ALCHEMIA LIMITED (AU) 2011-08-18 US disclosed
US-7875707-B2 combinatorial libraries; lipid solubility; solid phase synthesis ALCHEMIA LIMITED (AU) 2011-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110201794-A1 Disaccharides for drug discovery UGCG, STT3A, DDOST LMNA 4500/4885ALDH1A1 2021/4885ALOX12 3840/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.